Immunochemicals: Market Research Report

Date: April 1, 2012
Pages: 633
Price:
US$ 4,500.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IE0474D6255EN
Leaflet:

Download PDF Leaflet

Immunochemicals: Market Research Report
This report analyzes the worldwide markets for Immunochemicals in US$ million by the following Product Segments: Catalog Antibodies, and Custom Antibodies.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, China, and Rest of World.

Annual estimates and forecasts are provided for the period 2009 through 2017.

Also, a six-year historic analysis is provided for these markets.

The report profiles 129 companies including many key and niche players such as Abbott Diagnostics, Advanced ImmunoChemical, Beckman Coulter, Inc., BioCat GmbH, BIOTREND Chemikalien GmbH, Bio-Rad Laboratories, Inc., Dako, Life Technologies Corporation, Maine Biotechnology Services, Meridian Life Science®, Inc., Millipore Corporation, MitoSciences, Inc., MorphoSys AG, Randox Laboratories Ltd., Roche Group, Rockland Immunochemicals, Sigma-Aldrich Co., and Trinity Biotech, PLC.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Catalog Antibodies
Custom Antibodies

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Escalating Demand for Immunochemicals
Antibodies: Critical Role in Drug Discovery and Research
Animal-Based Technologies Lose Ground to Alternative Approaches
Emerging Markets Offer Huge Potential
Custom Antibodies: Finding Favor in Research Applications
Research Antibodies– Linked to Prospects of Therapeutic Antibody Market
Antibody Manufacturers Face Threat from Academics Sector

Table 1. Global Immunochemicals Market (2010): Percentage Share Breakdown of Revenues by Sector for Academic and Pharmaceutical & Biotech (includes corresponding Graph/Chart)

Competitive Scenario
Factors Affecting Competitiveness of Players in the Global Immunochemicals Market – Ranked by Importance for Purchasers

2.AN INTRODUCTION TO IMMUNOCHEMICALS

Immunochemicals
Types of Immunochemicals
Catalog Antibodies
Custom Antibodies
Applications of Immunochemicals
Healthcare
Environmental Science
Crop Protection and Biotechnology
Leading Research Areas

Table 2. Leading Research Areas in the Global Immunochemicals Market (2010): Percentage Share Breakdown for Immunology, Neurobiology, Signal Transduction, Developmental Biology, Cardiovascular, Virology, and Others (includes corresponding Graph/Chart)

Common Techniques Used for Research in the Global Immunochemicals Market

3.ANTIBODIES – A PRIMER

Introduction to Antibodies
Primary and Secondary Antibodies
Antibodies in Research Applications

Table 3. Antibody Usage in Research Sector (2009): Percentage Share Breakdown of Revenues by Platform for Flow Cytometry, ELISA, Protein Arrays, and Others (includes corresponding Graph/Chart)

Monoclonal Antibodies
Properties
Applications
Polyclonal Antibodies
Production Process
Properties
Applications
Conjugate Antibodies

4.MONOCLONAL ANTIBODY MARKET – AN OVERVIEW

Introduction
Asia: A Lucrative Market
China – The Fastest Growing mAb Market
Significant Growth in Therapeutic and Diagnostic Applications
Shift Towards Humanized and Fully Human Antibodies
Advancements & Challenges in Antibody Production Processes
Future of mAbs – Smaller and Inexpensive to Produce
Structurally Modified Full-Size mAbs – Next Type of mAbs to Hit the Market
MAb Fragments
Challenges Facing mAb Market
High Manufacturing and Development Cost
Mode of Administration
Strong Competition
Expiration of Patents
Immunogenicity
Regulatory Concerns
Competitive Scenario

5.PRODUCT INTRODUCTIONS/INNOVATIONS

AMSBIO Introduces Rabbit Monoclonal and Polyclonal Antibodies Portfolio
Immunocore Initiates Clinical Trials for IMCgp100
bioMérieux Introduces VIDAS® EBV
PerkinElmer Introduces LANCE® Ultra Assay Products
Radiometer Introduces NT-proBNP in AQT90 FLEX Immunoassay Analyzer Test Menu
Radiometer Introduces C-Reactive Protein in AQT90 FLEX Immunoassay Analyzer
Diagnostic Biosystems Introduces IVD Labeled Staining Reagents Range
Radiometer Adds β - hCG Pregnancy Marker to AQT90 FLEX Immunoassay Analyzer
Qualigen Introduces FastPack® hCG Immunoassay
Enterix Launches InSure® Quik F I T™ Fecal Immunochemical Test
Amgen Introduces Vectibix
Trevigen Introduces Mouse Monoclonal Antibody

6.RECENT INDUSTRY ACTIVITY

Abcam Takes Over MitoSciences
Rockland Immunochemicals Receives Grants from NIH
Bio-Rad Laboratories Acquires Diagnostic Businesses from Biotest
Beckman Coulter Takes Over Diagnostic Business of Olympus
Roche Takes Over Genentech
GED Capital to Acquire Majority Stake in Diamedix
PerkinElmer Enters into Collaboration with BioLegend
Abbott Inks Agreement with BG Medicine
Ortho Clinical Diagnostics Receives FDA Approval for VITROS® HBsAg Assay
Athera Inks Agreements with Oxford Biosystems and Asbach Medical Products
CTI Acquires AVANT Immunotherapeutics
Clinical Genomics Enters into Global License Agreement with Quest Diagnostics
Sigma-Aldrich Obtains Seppro Affinity Depletion Technology from GenWay Biotech
Siemens to Merge with Siemens Healthcare Diagnostics
Merck Acquires Bangalore Genei
Commonwealth Biotechnologies to Purchase GL Biochem
Intercell Takes Over Iomai
Thermo Fisher Scientific Takes Over Open Biosystems
Thermo Fisher Scientific Acquires Affinity BioReagents
Daiichi Sankyo Takes Over U3 Pharma
IMUC Completes Molecular Antibody Technology Acquisition
EUSA Pharma to Take Over Cytogen
Access Pharmaceuticals Acquires Somanta Pharmaceuticals
Genmab Enters into Antibody Research Collaboration with Pepscan
BTI Enters into an Agreement with Raven
Eusa Sells Antibody Research Business
AVANIR Inks Definitive Agreement to Divest Anthrax Antibodies
CG Therapeutics and UoW Agree for Joint Monoclonal Antibody Program
SDI to Develop mAbs for SAIC-F and NCI
Morphotek and HMI in Licensing Agreement
Amgen Enters into Licensing Agreement with Kyowa Hakko
Dyax and Sanofi-Aventis Sign Agreements
HGS Enters into Antibody Collaboration Agreement with Xencor
Biogen Partners with Genentech and Roche for Development of GA-101
Tecan Commences Operations at Refurbished Facility

7.FOCUS ON SELECT GLOBAL PLAYERS

Abbott Diagnostics (UK)
Advanced ImmunoChemical (US)
Beckman Coulter, Inc. (US)
BioCat GmbH (Germany)
BIOTREND Chemikalien GmbH (Germany)
Bio-Rad Laboratories, Inc. (US)
Dako (Denmark)
Life Technologies Corporation (US)
Maine Biotechnology Services (US)
Meridian Life Science®, Inc. (US)
Millipore Corporation (US)
MitoSciences, Inc. (US)
MorphoSys AG (Germany)
Randox Laboratories Ltd. (UK)
Roche Group (Switzerland)
Rockland Immunochemicals (US)
Sigma-Aldrich Co (US)
Trinity Biotech, PLC (Ireland)

8.GLOBAL MARKET PERSPECTIVE

Table 4. World Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 5. World Historic Review for Immunochemicals by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 6. World 15-Year Perspective for Immunochemicals by Geographic Region – Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, China and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 7. World Recent Past, Current & Future Analysis for Catalog Antibodies by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 8. World Historic Review for Catalog Antibodies by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 9. World 15-Year Perspective for Catalog Antibodies by Geographic Region – Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, China and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)
Table 10. World Recent Past, Current & Future Analysis for Custom Antibodies by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 11. World Historic Review for Custom Antibodies by Geographic Region – US, Canada, Japan, Europe, China and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 12. World 15-Year Perspective for Custom Antibodies by Geographic Region – Percentage Breakdown of Annual Revenues for US, Canada, Japan, Europe, China and Rest of World Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

Market Analysis

Table 13. US Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 14. US Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 15. US 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

2.CANADA

Market Analytics

Table 16. Canadian Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 17. Canadian Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 18. Canadian 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

3.JAPAN

Market Analysis

Table 19. Japanese Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 20. Japanese Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 21. Japanese 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

4.EUROPE

Market Analytics

Table 22. European Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 23. European Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 24. European 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

5.CHINA

A. Market Analysis
A Rapidly Expanding mAb Market
Strengths and Opportunities
Target-Specific Nature of Monoclonal Antibodies
Rising Incidence of Cancer & Age-Related Conditions: Potential Opportunity
Manufacturing Advancements
High Cost of mAb Treatment in the EU and US
B. Market Analytics

Table 25. Chinese Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 26. Chinese Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 27. Chinese 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

6.REST OF WORLD

A. Market Analysis
Asia Offers Enormous Opportunities for mAb Market
B. Market Analytics

Table 28. Rest of World Recent Past, Current & Future Analysis for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
Table 29. Rest of World Historic Review for Immunochemicals by Type – Catalog Antibodies and Custom Antibodies Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
Table 30. Rest of World 15-Year Perspective for Immunochemicals by Type – Percentage Breakdown of Annual Revenues for Catalog Antibodies and Custom Antibodies Markets for Years 2003, 2011 & 2017 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 129 (including Divisions/Subsidiaries - 136)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Skip to top


Siding Industry: Market Research Report US$ 4,500.00 Jan, 2016 · 301 pages
Titrators (Automatic and Manual): Market Research Report US$ 4,500.00 Jan, 2016 · 173 pages
Stethoscopes: Market Research Report US$ 4,950.00 Jan, 2015 · 230 pages
L-Carnitine: Market Research Report US$ 4,200.00 Mar, 2012 · 209 pages

Ask Your Question

Immunochemicals: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: